| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | Lin Yan | |
| Edward L Spitznagel | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 1155-1163 | |
| P577 | publication date | 2009-02-11 | |
| P1433 | published in | American Journal of Clinical Nutrition | Q7713500 |
| P1476 | title | Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis | |
| P478 | volume | 89 |
| Q36116269 | A Perspective on Prostate Carcinogenesis and Chemoprevention |
| Q34125778 | A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensity |
| Q37692124 | Activation of the EIF2α/ATF4 and ATF6 Pathways in DU-145 Cells by Boric Acid at the Concentration Reported in Men at the US Mean Boron Intake |
| Q38107513 | Advances in prostate cancer chemoprevention: a translational perspective. |
| Q22241237 | American Cancer Society guidelines on nutrition and physical activity for cancer prevention |
| Q38632579 | An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health |
| Q47882131 | Association of isoflavone biomarkers with risk of chronic disease and mortality: a systematic review and meta-analysis of observational studies. |
| Q38032972 | Can breast cancer patients use soyafoods to help reduce risk of CHD? |
| Q37616452 | Cancer incidence among Asian American populations in the United States, 2009-2011. |
| Q46495297 | Cancer incidence in Canada: trends and projections (1983–2032). |
| Q34991880 | Chemoprevention of prostate cancer with nutrients and supplements. |
| Q59511463 | Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls |
| Q35757520 | Coffee and beverages are the major contributors to polyphenol consumption from food and beverages in Japanese middle-aged women. |
| Q39438812 | Correlation between Oxidative Stress, Nutrition, and Cancer Initiation. |
| Q39435846 | DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines |
| Q37244017 | Design and selection of soy breads used for evaluating isoflavone bioavailability in clinical trials. |
| Q90088937 | Diet, nutrition, and cancer risk: what do we know and what is the way forward? |
| Q38211784 | Dietary factors affecting polyphenol bioavailability |
| Q45213096 | Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort |
| Q28534575 | Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor |
| Q37988309 | Does equol production determine soy endocrine effects? |
| Q38824693 | Does soy protein affect circulating levels of unbound IGF-1? |
| Q26827438 | East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians |
| Q37577822 | Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial |
| Q34357401 | Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer |
| Q37905857 | Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist |
| Q37512708 | Equol production changes over time in postmenopausal women |
| Q35870029 | Equol production changes over time in pre-menopausal women |
| Q36758880 | Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes |
| Q37710419 | Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
| Q82425750 | Fermented and non‐fermented soy food consumption and gastric cancer in Japanese and Korean populations: A meta‐analysis of observational studies |
| Q37687437 | Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies |
| Q40845275 | Flavonoids intake and risk of prostate cancer: a meta-analysis of observational studies |
| Q35073592 | Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway |
| Q83969593 | Further opportunities for cost reduction of medical care |
| Q89468989 | Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line |
| Q26801271 | Genistein and cancer: current status, challenges, and future directions |
| Q38215654 | Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis |
| Q34396048 | Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. |
| Q38609844 | Health impact of childhood and adolescent soy consumption |
| Q47692407 | Intake of Individual Flavonoids and Risk of Carcinogenesis: Overview of Epidemiological Evidence |
| Q53358182 | Interaction effects between genes involved in the AKT signaling pathway and phytoestrogens in gastric carcinogenesis: a nested case-control study from the Korean Multi-Center Cancer Cohort. |
| Q26801110 | Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter |
| Q38878301 | Is There a Future for Chemoprevention of Prostate Cancer? |
| Q38853399 | Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases |
| Q64077130 | Isoflavones |
| Q36705608 | Isoflavones and Prostate Cancer: A Review of Some Critical Issues |
| Q40236231 | Legume intake and risk of prostate cancer: a meta-analysis of prospective cohort studies |
| Q34087153 | Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits |
| Q38061846 | Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. |
| Q45237128 | Metabolic studies of four soy isoflavones in rats by HPLC-HR-MS. |
| Q36628651 | New acyclic bis phenylpropanoid and neolignans, from Myristica fragrans Houtt., exhibiting PARP-1 and NF-κB inhibitory effects |
| Q34614720 | Nutraceuticals and prostate cancer prevention: a current review. |
| Q42956899 | Nutrients and risk of prostate cancer |
| Q34036877 | Nutritional update for physicians: plant-based diets |
| Q35028222 | Pattern of prostate cancer presentation among the Egyptian population: A study in a single tertiary care center |
| Q39264461 | Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy |
| Q33452595 | Phytoestrogen biomonitoring: an extractionless LC-MS/MS method for measuring urinary isoflavones and lignans by use of atmospheric pressure photoionization (APPI). |
| Q38558029 | Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies |
| Q30244993 | Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies |
| Q38725799 | Phytosteroids beyond estrogens: Regulators of reproductive and endocrine function in natural products. |
| Q37641962 | Plant-derived alternative treatments for the aging male: facts and myths |
| Q35651999 | Plasma genistein and risk of prostate cancer in Chinese population |
| Q36013544 | Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC. |
| Q38950711 | Prevalence and management of prostate cancer among East Asian men: Current trends and future perspectives. |
| Q37794799 | Prevention Strategies in Prostate Cancer |
| Q43594513 | Probiotics: a proactive approach to health. A symposium report |
| Q40402465 | Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts |
| Q36657403 | Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial. |
| Q37988932 | Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome". |
| Q38193300 | Prostate cancer in Asian men. |
| Q33802558 | Prostate cancer progression and mortality: a review of diet and lifestyle factors |
| Q39374516 | Prostate cancer trends in Asia |
| Q33818800 | Recent progress on nutraceutical research in prostate cancer |
| Q38000980 | Regulation of the immune response by soybean isoflavones |
| Q35420301 | Review article: health benefits of some physiologically active ingredients and their suitability as yoghurt fortifiers |
| Q36375316 | Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates |
| Q37857841 | Risks and benefits of dietary isoflavones for cancer |
| Q34458421 | Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer |
| Q34848018 | Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial |
| Q36719209 | Sociodemographic and lifestyle variables are compound- and class-specific correlates of urine phytoestrogen concentrations in the U.S. population |
| Q40441026 | Soy Food Intake and Biomarkers of Breast Cancer Risk: Possible Difference in Asian Women? |
| Q28071946 | Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature |
| Q34992997 | Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials |
| Q53294161 | Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. |
| Q35335557 | Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk |
| Q47230001 | Soy, Soy Foods and Their Role in Vegetarian Diets |
| Q30835235 | Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons |
| Q60495395 | Soya and isoflavone intakes associated with reduced risk of oesophageal cancer in north-west China |
| Q35850102 | The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells |
| Q36924955 | The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model. |
| Q28305639 | The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentation |
| Q33676455 | The potential health effects of dietary phytoestrogens |
| Q41563248 | The relationship between fermented food intake and mortality risk in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort |
| Q24604956 | The relationship between nutrition and prostate cancer: is more always better? |
| Q34416254 | The role of estrogen receptor β in prostate cancer |
| Q39651231 | The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts |
| Q34247970 | The role of soy in vegetarian diets |
| Q44312728 | The short-term effects of soybean intake on oxidative and carbonyl stress in men and women. |
| Q38175776 | The strategies to control prostate cancer by chemoprevention approaches |
| Q35846299 | Vegetable and fruit intake after diagnosis and risk of prostate cancer progression |
| Q33856030 | What should we tell prostate cancer patients about (secondary) prevention? |
| Q97530490 | Why has Japan become the world's most long-lived country: insights from a food and nutrition perspective |
Search more.